Achieving Optimal Medical Therapy: Insights From the ORBITA Trial

BACKGROUND: In stable coronary artery disease, medications are used for 2 purposes: cardiovascular risk reduction and symptom improvement. In clinical trials and clinical practice, medication use is often not optimal. The ORBITA (Objective Randomised Blinded Investigation With Optimal Medical Therap...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Am Heart Assoc
Main Authors: Foley, Michael, Rajkumar, Christopher A., Shun‐Shin, Matthew, Ganesananthan, Sashiananthan, Seligman, Henry, Howard, James, Nowbar, Alexandra N., Keeble, Thomas R., Davies, John R., Tang, Kare H., Gerber, Robert, O’Kane, Peter, Sharp, Andrew S. P., Petraco, Ricardo, Malik, Iqbal S., Nijjer, Sukhjinder, Sen, Sayan, Francis, Darrel P., Al‐Lamee, Rasha
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2021
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7955412/
https://ncbi.nlm.nih.gov/pubmed/33496201
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.120.017381
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados